Author

L. B. Hersh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

K. M. Chow· 2 shared A. Gomes· 1 shared A. Goswami· 1 shared A. J. Schultz· 1 shared C. A. Olleig· 1 shared C. N. Smith· 1 shared D. Deredge· 1 shared D. W. Rodgers· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

K. M. Chow

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivMay 30, 2023

Structure of puromycin-sensitive aminopeptidase and polyglutamine binding

S. Madabushi, K. M. Chow, E. S. Song…·D. W. Rodgers

The paper reports the crystal structure of puromycin-sensitive aminopeptidase and describes its interaction with polyglutamine.

DOI 10.1371/journal.pone.0287086

protein structureexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivMay 13, 2021

Toxoplasma gondii Toxolysin 4 contributes to efficient parasite egress from host cells

M.-H. Huynh, M. Roiko, A. Gomes…·V. B. Carruthers

This study identifies Toxolysin 4 (TLN4) as a metalloproteinase necessary for efficient Toxoplasma gondii egress from host cells.

DOI 10.1128/msphere.00444-21

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

BiochemistrybioRxivPreprintOct 2, 2020

Development and validation of nanobodies specifically targeting the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3)

C. N. Smith, K. Kihn, Z. A. Williamson…·J. S. Blackburn

This paper develops and validates nanobodies that specifically target PRL-3, showing high specificity over PRL-1 and PRL-2 and providing tools to study PRL-3 function in cancer.

DOI 10.1101/2020.10.02.311787

humanexperimental assay

𝕏 PostBluesky